To identify a set of genes related to radiosensitivity of cervical squamous cell carcinomas and to establish a predictive method, we compared expression profiles of 9 radiosensitive and 10 radioresistant tumors obtained by biopsy before treatment, on a cDNA microarray consisting of 23,040 human genes. We identified 121 genes whose expression was significantly greater in radiosensitive cells than in radioresistant cells, and 50 genes that showed higher levels of expression in radioresistant cells than in radiosensitive cells. Some of these genes had already known to be associated with the radiation response, such as aldehyde dehydrogenase 1 ( ALDH1 ) and X -ray repair cross -complementing 5 (XRCC5 ) (P < .05, Mann -Whitney test ). The validity of the total of 171 genes as radiosensitivity related genes were certified by permutation test ( P < .05 ). Furthermore, we selected 62 genes on the basis of a clustering analysis, and confirmed the validity of these genes with cross -validation test. The cross -validation test also indicates the possibility of making prediction of radiosensitivity for discriminating radiation -sensitive from radiation resistant biopsy samples by predicting score ( PS ) values calculated from expression values of 62 genes in 19 samples, because the prediction successfully and unequivocally discriminated the radiosensitive phenotype from the radioresistant phenotype in our test panel of 19 cervical carcinomas. The extensive list of genes identified in these experiments provides a large body of potentially valuable information for studying the mechanism( s ) of radiosensitivity, and selected 62 genes opens the possibility of providing appropriate and effective radiotherapy to cancer patients.
Introduction
Although proper diagnosis and effective treatments for cervical cancers are widely available now [ 1 ] , this disease is still a leading cause of death for women worldwide [ 2 ] .
Radiotherapy is a generally effective therapeutic method, particularly for patients with cancers at an advanced stage. However, individual patients may show quite different patterns of response against radiotherapy; some can be cured, but others cannot, and the latter may therefore suffer needlessly from severe side effects. Hence, if treatment is to become more patient specific, the molecular mechanism( s ) of radiosensitivity need to be clarified.
Several molecular markers that reflect radiosensitivity have been proposed as the result of studies that have involved, for example, transfection of oncogenes such as N -ras, v -myc with H -ras, and v -fos into cultured cells to induce a radioresistant phenotype [ 3, 4 ] . Activation of c -raf -1 has been positively correlated with radioresistance of head and neck squamous cell carcinomas [ 5 ] , and certain cell cycle -and apoptosis -related genes also have been correlated with radiosensitivity; e.g., loss or dysfunction of p16 renders melanoma cells resistant to ionizing radiation, whereas expression of exogenous wild -type p16 and p21 in glioblastoma cells can induce radiosensitivity [ 6, 7 ] . Transfection -or radiation -induced expression of Bcl -2 proteins, which regulate apoptosis, into pro -myeloid cells has introduced a radioresistant phenotype [ 8, 9 ] ; furthermore, expression of Bax, when induced by gamma irradiation, confers radiosensitivity on lymphoid cells, small intestinal epithelial cells [ 10 ] and cervical cancer cells [ 9 ] . However, although such discoveries have brought partial understanding of the molecular mechanisms responsible for cellular radiosensitivity, the whole picture remains to be clarified.
Because the complex mechanism of radiosensitivity cannot be explained by a small number of genes, we need to collect genome -wide information about all the genes involved. To that end, we recruited a newly developed technique, cDNA microarray [ 11 ] , which provides highthroughput analysis of expression profiles by means of small -array slides spotted with cDNAs [ 12 -15 ] .
Here we report a genome -wide cDNA microarray analysis of 23,040 human cDNAs, in biopsy samples from 19 cervical squamous carcinomas ( 9 of them radiosensitive and 10 radioresistant, classified according to tumor -suppression ratios ). We identified 171 genes that were differentially expressed between the two groups; of those, 121 showed elevated expression and 50 showed decreased expression in radiosensitive tumor cells relative to their expression levels in radioresistant cells. In addition, further selected 62 genes showed feasibility of predicting the radiosensitivity of cervical squamous cell carcinomas. These results not only disclose the complex nature of radiosensitivity as regards the response of cervical squamous cell carcinomas to ionizing radiation, but also provide information that should identify novel targets for efforts to expand the effectiveness of radiotherapy.
Materials and Methods

Tissue Samples
Cervical squamous cell carcinoma tissues were obtained with informed consent from 19 patients who underwent biopsy before radiotherapy at Kansai Medical University, and snap -frozen at À 808C. All cases were at stages IIB to IVB, and were papillomavirus ( HPV) -positive. We observed the population of tumor cells in all biopsy samples was over 90% by hematoxylin and eosin staining. Methods for typing of HPV and establishing p53 status were described previously [9] .
Radiation Treatments
All 19 patients were treated with radiotherapy after sampling. A total of 30.6 Gy was provided to the whole pelvis, plus an additional dose to parametria with central shielding to complete 52.2 Gy, along with 192 Ir high doserate intracavitary brachytherapy. Details have been described elsewhere [ 9 ] . Effects of the therapy, including local failure, were checked a month after treatment. Nine patients revealed 100% reduction in tumor size and the remaining 10 showed 0% to 40% reduction ( Table 1 ) . The former were classified as a radiosensitive group ( complete response; [ CR ] ) and the latter as a radioresistant group ( no change [ NC ] ).
RNA Extraction and Amplification
Total RNAs were extracted from each specimen by TRIZOL ( Invitrogen, Life Technologies, Carlsbad, CA ) according to the manufacturer's protocol. The extracted RNAs were treated for 1 hour at 378C with 10 U of DNase I ( Nippon Gene, Japan ) in the presence of 1 U of RNase inhibitor ( TOYOBO, Osaka, Japan ), to remove any contaminating genomic DNA. After inactivation of DNase at 708C for 10 minutes, the RNAs were purified with phenolchloroform -isoamyl alcohol ( Gibco BRL, Grand Island, NY ) and then precipitated by ethanol. Next, all DNase I -treated RNAs were subjected to T7 -based RNA amplification as described previously [ 16 ] . Two rounds of amplification yielded 65 to 152 g of amplified RNA ( aRNA ) from each sample. As a control for comparing gene expression profiles between the CR and NC groups on the microarray, we performed two rounds of T7 -RNA amplification using a mixture of poly A + RNAs from tissues of 12 normal human organs ( brain, heart, liver, skeletal muscle, small intestine, spleen, placenta, thyroid, fetal brain, fetal kidney, fetal lung, and fetal liver ) purchased from Clontech (Palo Alto, CA) as a control.
Microarray Design, Production, and Hybridization We selected 23,040 cDNA clones from the UniGene database of the National Center for Biotechnology Information (Bethesda, MD) ( build #131 ). Our cDNA microarray was constructed essentially as described previously [ 13 ] ; 2.5 g of aRNA from each cervical carcinoma was labeled with Cy5 -dCTP and the control aRNA was labeled with Cy3 -dCTP by a protocol described elsewhere [ 13 ] . Hybridization, washing, and scanning were carried out according to published methods [ 13 ] .
Data Analysis and Selection of Differentially Expressed Genes
Signal intensities of Cy3 and Cy5 from the 23,040 spots were quantified by the Array vision software ( Amersham Biosciences, Piscataway, NJ ) and normalized as described previously [ 12 ] . In the quantification step, local background correction method was adopted. Because the data were unreliable when intensities fell below 2.5Â10 5 relative fluorescent units or signal to noise ratios were below 3.0 However, because more than half of these genes have small differences in expression level between CR and NC group, the difference might be caused by data fluctuation. Therefore, genes showing differences more than double the median expression value between the two groups ( X CR / X NC Q0.5 or R2.0, where X CR and X NC indicate median X values for the CR or NC group, respectively ) were defined as radiosensitivity ( or radioresistance ) related genes. A total of 171 genes were selected ( 121 were significantly greater in radiosensitive cells than in radioresistant cells, and 50 were higher levels of expression in radioresistant cells than in radiosensitive cells ).
Permutation Test
To further evaluate the validity of 171 genes selected by Mann -Whitney tests, permutation test was performed as described previously [ 18 ] , and the probabilities of the genes to be correlated to group distinction, Ps, were also estimated. When each gene was represented by expression vector v( g )=(X 1 , X 2 , . . ., X 19 ), where X i denotes the expression level of gene of the ith sample in the initial set of samples, idealized expression patterns were represented by c =(c 1 , c 2 , . . ., c 19 ) , where c i = + 1 or 0 according to whether the ith sample belongs to the CR or NC group. The correlation between a gene and a group distinction P gc was defined as follows: i.e., P gc =( CR À NC )/( CR + NC ), where CR ( NC ) and CR ( NC ) indicate the means and the standard deviations of log 2 X of the gene ''g'' for each sample in newly defined CR ( NC ) group. Permutation test was conducted by permuting the coordinates of c 10,000 times. During every permutation, the correlation values, P gc s, were calculated. These procedures were performed 10,000 times, repeatedly. On the hypothesis that these obtained 10,000 A g values show ideal normal distribution, P values, which imply probability of the genes to classify the two groups by chance was estimated for each selected 171 gene.
Hierarchical Clustering
These 171 genes were subjected to a hierarchicalclustering protocol using ''Cluster'' and ''Tree view'' software written by M. Eisen [ 17 ] . Before applying the clustering algorithm, gene -expression values ( X ) for each gene in each of the 19 samples were log -transformed ( log 2 X ). After that all values in each row and / or column of data were multiplied by scale factor S, so that the sum of the squares of the values in each row and column was 1.0 ( a separate S is computed for each row / column ). Next, row -wise and column -wise median values were subtracted from the values in each row and / or column data, so that the median value of each row and / or column is 0. Hierarchical clustering was performed using distance metrics based on Pearson correlation and adopting Average Linkage Clustering method.
Cross -Validation Test
The selected 62 genes from 171 genes by clustering experiment were subjected to cross -validation test. Among the total 19 samples tested above, one sample was withheld as test sample and the other 18 samples were used for building predictor according to the method as described previously [ 18 ] . Next, predictive score ( PS ) for test sample was calculated as follow; PS = P V g , where
, and
indicates the means and standard deviations of log 2 X of the gene ''g'' for each sample in the CR ( NC ) group defined as predictor samples. X g denotes the log 2 X of the gene ''g'' for test sample. Finally, the predictor sample and test sample were changed and then PS for new test sample was calculated. This process was performed 19 times, repeatedly.
Results
Identification of Genes Responding to Radiation
We performed cDNA microarray analysis of gene expression in 19 cervical -cancer materials, of which 9 were radiation sensitive and 10 were radiation resistant on clinical grounds. By means of the Mann -Whitney test ( P < .05 ) and subsequent procedures ( see Materials and Methods section ), we selected a total of 171 genes ( including 74 ESTs ) as being differently expressed between CR ( complete response ) and NC ( no change ) groups. Of those 171 genes, 121 ( including 62 ESTs ) revealed increased expression, and 50 ( including 12 ESTs ) showed decreased expression, in carcinomas belonging to the CR group compared with the NC group ( Table 2, A and B ). Genes involved in adipogenesis and in the MAP kinase pathway were significantly upregulated in the CR group compared to the NC group; the former included aldehyde dehydrogenase 1 (ALDH1 ), and retinol -binding protein 1 ( RBP1; Figure  1A ). The latter included mitogen -activated protein kinase kinase kinase 2 ( MAP3K2 ), G protein beta subunit -like ( GBL ), and RAB5C ( a member of the RAS oncogene family ). However, genes that are considered to be associated with repair of breaks in double -stranded DNA, including X -ray repair cross -complementing 5 ( XRCC5; Figure 1B ) were downregulated in the CR group relative to Genes that are Involved in Radiosensitivity Kitahara et al. 299 the NR group. In addition, a number of genes related to DNA repair, transcription, signal transduction, cell skeleton, and adhesion were among those expressed differently in the two groups.
Permutation Test
To evaluate the validity of the 171 genes selected as radiosensitivity -related genes, permutation test was performed as described in the Materials and Methods section. Expression levels of each 19 samples in both groups for each gene were permuted ( randomly scrambled ) 10,000 times. P gc values were calculated using CR , NC , CR , and NC values derived from newly classified CR group and NC group during every permutation. Large absolute values of P gc indicate a strong correlation between the gene expression and the class distinction, whereas the sign of P gc being positive or negative corresponds to gene ''g'' being more highly expressed in the CR or NC group. After the 10,000 times permutation, the probabilities of the genes to be correlated to group distinction, Ps, were estimated under the hypothesis that these 10,000 P gc values show ideal normal distribution ( Table 2 , A and B ). As a result, all of the selected 62 genes showed P values >.05 without exception. Hence, it was proved that these selected 171 genes were to be radiosensitivity predictive gene under the confidence of P < .05.
Hierarchical Clustering
Of these 171 genes were subjected to hierarchical clustering as described in the Materials and Methods section. This procedure clearly separated the two groups from each other, except for tumor No. 47 ( data not shown ). To achieve complete separation, we selected 62 genes that showed greater than 2.0 standard deviations of expression values among all 19 samples. Cluster analysis using these 62 genes achieved complete separation of the groups ( Figure 2 ).
Cross -Validation Test
Cross -validation test was performed to examine whether the 62 genes were crucial for classifying CR and NC groups and whether they could predict the group for test samples. Among the 19 samples, 18 samples were used for group predictor and 1 sample was used as the test sample. The sample sets of predictor and test sample were changed 19 times and PS for each 19 samples was calculated as described in the Materials and Methods section ( Figure 3 and Table 3 ). Threshold line for PSs to discriminate CR or NC group were settled at the half point between average PS values of the CR group and that of the NC group: À 12. As shown in Figure 3 , PSs for samples in CR and NC groups were clearly separated, except for sample No.74 ( error ratio was 5.3% ( = 1 sample / 19 samples ) ).
Discussion cDNA Microarray analysis is a powerful tool for obtaining comprehensive information about expression of thousands of genes in cancer cells [ 12 -15 ] . By combining this technology with statistical analysis, we identified 171 genes that showed different expression patterns between two distinct clinical groups and, therefore, were likely to reflect differences in the response of cervical cancer cells to radiotherapy. To examine the validity of 171 genes selected as radiosensitivity -related genes, random permutation test was performed by calculating P gc s, and P values for each gene were evaluated. After 10,000 times permutation test, P values for all of the 171 genes were lower than .05, indicating that these genes were significantly correlated to radiosensitivity. Furthermore, in a clustering analysis, the expression profiles of these 171 genes were able to classify each of 19 tumor samples, except for one, to the appropriate group ( radiosensitive or radioresistant ). However, when the cluster analysis was limited to 62 genes having greater than 2.0 standard deviations of expression level across the 19 samples, all tumors were properly classified into their respective groups. To further evaluate the validity of 62 genes selected as radiosensitivity -related genes, we carried out cross -validation test. After 19 times cross -validation test, each PS value for each sample that belonged to the CR ( or NC ) group showed higher ( or lower ) value than threshold line. This study not only supports the feasibility of these 62 genes as radiosensitivity -related genes, but also indicates the possibility of predicting radiosensitivity for discriminating radiation -sensitive from radiation -resistant biopsy samples by PS values calculated from expression values of 62 genes. However, further study with additional tumor samples would be required to apply these genes for predicting radiosensitivity of tumors in patients before therapy begins. Because all of the cervical cancer samples we used in this study were human papillomavirus ( HPV )-positive, p53 as well as RB functions were likely to be eliminated by the viral protein [ 19 ] . Hence, the set of genes listed here may be associated with a cell -death pathway independent of p53. Radiation kills tumor cells mainly as a result of double -strand breaks ( DSBs ) in DNA [ 20 ] . If cells are defective in their DNA -repair systems, especially as regards DSB repair, they should be more susceptible to cell death. The gene product of XRCC5, Ku80, a protein that binds double -stranded DNA and a component of DNA -dependent protein kinase holo enzyme, is involved in DSB repair [ 21 ] . XRCC5 -deficient cells and Ku80 -knockout mice are hypersensitive to ionizing radiation [ 22, 23 ] . Therefore, the higher expression of this gene we observed in radioresistant cancer cells accords with its physiological function. XRCC5 would be one of the most crucial genes for determining the fate of cells under the genotoxic stress caused by irradiation. We also observed a relatively higher level of expression of lactate dehydrogenase ( LDHA ), which aids glycolysis under hypoxic conditions [ 24 ] in radioresistant cells. Cells in fact become radioresistant under hypoxic conditions [ 25 ] , and a high level of LDHA expression could be an important mechanism conferring radioresistance.
In radiosensitive cells, we found elevated expression of adipogenesis -related genes including ALDH1 and RBP1. The product of ALDH1 is involved in retinoic acid ( RA ) synthesis [ 26 ] and RBP1 is a transporter of retinol. Cervical carcinoma cells treated with RA before irradiation are reported to become radiosensitive [ 27 ] ; furthermore, RA induces TRAIL expression and causes apoptosis [ 28 ] . Therefore, elevated expression of these genes may induce RA synthesis and, thereby, encourage apoptosis after radiation.
Our list of 171 genes should be useful not only as an aid to understanding the mechanism of radiosensitivity, but also as a means to expand the possibilities for effective radiotherapy. For example, if some novel drugs could block gene products that are involved in radioresistance, or if genes that induce apoptotic signals after radiation could be exogenously introduced, the effectiveness of radiotherapy would be increased. In addition, the 62 selected genes might prove of great benefit for diagnosing radiosensitivity of individual cervical cancers, to provide opportunities for selecting appropriate treatment ( personalized medicine ) for each patient.
